Clinical Trial Update: A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating megestrol acetate modulation in hormone receptor-positive advanced breast cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasm

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Breast Neoplasm | Phase 2 | Status: UNKNOWN